Lorin NSA

Lorin NSA Tablet Syrup contains Loratadine in it. Loratadine is an oral no sedating H-1-blocker. It is almost similar in structure to cyproheptadine and azatadine. Meanwhile it differs structurally from the other non-sedating H-blockers terfenadine and astemizole. It used to relief the symptoms associated with seasons allergic rhinitis.

More Useful Medications: Avamys Nasal Spray Uses

Lorin Composition

Each Lorin-NSA 10 mg tablet contains : Loratadine 10 MG

Each Lorin NSA 5 ML syrup contains : Loratadine 5 MG

Lorin NSA Uses

Lorin NSA (Loratadine) Tablet Syrup indicated for the relief of nasal and non-nasal symptoms of seasonal allergic rhinitis. Meanwhile it also use for the treatment of chronic idiopathic urticaria in patients 2 years of age or older.

Lorin NSA Dosage And Administration

Adults And Children 6 Years Of Age And Over:

The recommended Loratadine (Lorin NSA) Dose is one 10 mg tablet or 2 teaspoonfuls (10 mg) syrup once daily.

Children 2 To 5 Years Of Age And Over;

The recommended Loratadine (Lorin-NSA) Syrup Dosage is 5 5 mg (1 teaspoonful) once daily.

In Adults And Children 6 Years Of Age And Over with Liver Failure Or Renal Insufficiency (GFR< 30 mL/min):

The starting dose should be 10 mg (one tablet or two teaspoonfuls) every other day. In children 2 to 5 years of age with liver failure or renal insufficiency, the starting dosage should be 5 mg (one teaspoonful) every day.

Lorin NSA (Loratadine) Special Populations

Pediatric:

the pharmacokinetic profile of loratadine in children in the 2 to 12 years age age group is similar to that of adults.

Geriatric:

The mean elimination half-lives for the geriatric subjects were 18.2 hours for loratadine and 17.5 hours for descarboethoxylorateadine.

Renal Impairment:

The mean elimination half-lives of loratadne (7.6 hours) and descarboethoxyloratadine (23.9 hours) were not substantially different from that observed in normal subjects. Hemodialysis Does not have an effect on the pharmacokinetics of loratadine or descarbothoethoxyloratadine in subjects with chronic renal impairment.

Hepatic Impairment:

The elimination half-lives for loratadine and descarboethoxyloratadine were 24 hours and 37 hours, respectively, and increased with increasing severity of liver disease.

Lorin NSA (Loratadine) Side Effects

The most commonly reported Loratadine side-effects are

• Fatigue
• Dry mouth
• Allergic symptoms like rash
• Headache
• Gastrointestinal disturbances (e.g. gastric upsets/nausea)

Meanwhile, the more uncommon side-effects include alopecia, anaphylaxis and an abnormal hepatic functioning. On the other hand, less frequent incidences of abnormal hepatic function including hepatitis, jaundice and hepatic necrosis have reported.

Lorin NSA ( Loratadine) Drug Interactions

Most importantly, when administered concomitantly with alcohal, loratadine has no potentiating effects as measured by psychomotor studies. However, Increase in plasma concentrations of loratadine have reported after concomitant use with ketoconzole, erythromycin or cimetidine in controlled clinical trials. But only without clinically significant changes (including electrocardiographic). Meanwhile, other drugs known to inhibit hepatic metabolism should be co administered with caution until definitive interaction studies can completed.

Drug/Laboratory Test Interactions:

Loratadine should discontinued approximately prior to skin testing procedures since antihistamines may prevent or diminish otherwise positive reactions to dermal reactivity indications.

Lorin NSA (Loratadine) Precautions

General Precautions:

• Patients with liver impairment or renal insufficiency (GFR< 30 ml/min) should be given a lower initial dose (10 mg every other day).
• Loratadine lacks significant may effects. Patients should however be warned that a small number of individuals may experience sedation. Patients experiencing sedation or impaired concentration should be advised not be drive or perform complicated tasks. Sedation may be enhanced by the simultaneous intake of alcohol of other complicated system depressants.

Pregnancy Category B:

However, there was no evidence of animal teratogenicity. There are, however, no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of human response, loratadine should be used during pregnancy only if clearly needed.

Nursing Mothers:

Loratadine and its metabolite, descarbothoxyloratadine, pass easily into breast milk. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Caution should be exercised when loratadine is administered to a nursing women.

Pediatric Use:

Meanwhile, the safety of loratadine syrup at a daily dose of 10 mg demonstrated in 188 pediatric patients 6 to 12 years of age. On the other hand, the safety and tolerability of loratadine syrup at a daily dose of 5 mg has been demonstrated in 60 pediatric patients 2 to 5 years of age. However, the safety and effectiveness of loratadine in children under 2 years of age have been established.

Lorin-NSA (Loratadine) Overdosage

However, In adults, somnolence, tachycardia, and headache have reported with overdoses greater than 10 mg with the tablet formulation (40 mg -180 mg). Meanwhile, Extrapyramidal signs and palpitations reported in children with overdose of greater than 10 mg of loratadine syrup. Most importantly, In the event overdoses general symptomatic and supportive measures should instituted promptly and maintained for as long as necessary.

Treatment of overdosage would reasonably consist of emesis (ipecac syrup), expect in patients with impaired consciousness, followed by the administration of activated charcoal to absorb any remaining drug. If vomiting unsuccessful, or contraindicated, gastric lavage should performed with normal saline. Saline cathartics may also of value for rapid dilution of bowel contents. On the other hand, Loratadine not eliminated by hemodialysis. Meanwhile, It not known if loratadine eliminated by peritoneal dialysis.

Lorin-NSA (Loratadine) contraindications

Patients with known hypersensitivity to loratadine or any of the ingredients of Lorin-NSA Tablet Syrup.

Lorin-NSA (Loratadine) Tablet Syrup Storage Instructions

Most importantly, always remember to keep all your medicine out of the reach of your kids at home. On the other hand, protect Lorin-NSA Tablet Syrup from direct sunlight and heat. Meanwhile, also store the tablets and syrup below 30 C room temperature.

More Medicine Information: Zuring Tablets (Febuxostat) 40 MG, 80 MG Uses, Dosage, Side Effects

Lorin NSA (Loratadine) Tablets Syrup